Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV)

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions
Covid19SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

Blood count

Blood count at each visit

DIAGNOSTIC_TEST

Blood collection

Blood collection to understanding of the immunological profile at each visit

DIAGNOSTIC_TEST

Nasopharyngeal swab

Research of SARS-CoV-2 infection in nasopharyngeal swab by RT-PCR at day 8 and day 15

DIAGNOSTIC_TEST

Saliva samples

Research of SARS-CoV-2 infection in saliva samples at each visit (excepted inclusion)

DIAGNOSTIC_TEST

Faeces samples

Research of SARS-CoV-2 infection in faeces samples at day 3, day 15 and day 90

GENETIC

Genetic blood collection

Collection to further research at each visit

OTHER

Data collection

Demographics, symptoms, biological constants

Trial Locations (1)

75014

Hôpital Cochin, Paris

All Listed Sponsors
collaborator

Fonds IMMUNOV

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04703114 - Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) | Biotech Hunter | Biotech Hunter